The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience

被引：0
|
作者：
Jolanta Krajewska
Aleksandra Kukulska
Ewa Paliczka-Cieślik
Daria Handkiewicz-Junak
Tomasz Gawlik
Tomasz Olczyk
Aleksandra Kropińska
Aleksander Skoczylas
Barbara Michalik
Barbara Jarząb
机构：
[1] M. Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology,
[2] Gliwice Branch,undefined
来源：
Thyroid Research | / 6卷 / Suppl 2期
关键词：
Meningitis; Thyroid Cancer; Tyrosine Kinase Inhibitor; Lymphopenia; Prospective Clinical Trial;
D O I：
10.1186/1756-6614-6-S2-A33
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Treatment of anaplastic thyroid cancer with tyrosine kinase inhibitors targeted on the tumor vasculature: initial experience in clinical practice
    Ishihara, Sae
    Onoda, Naoyoshi
    Noda, Satoru
    Tauchi, Yukie
    Morisaki, Tamami
    Asano, Yuka
    Kashiwagi, Shinichiro
    Takashima, Tsutomu
    Ohira, Masaichi
    ENDOCRINE JOURNAL, 2021, 68 (01) : 63 - 68
  • [42] The impact of gastric acid suppression therapy on tyrosine kinase inhibitors in advanced cancer patients.
    Chu, Michael Patvin
    Ha, Vincent
    Ngo, Margaret
    Ghosh, Sunita
    Chambers, Carole
    Sawyer, Michael B.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [43] Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors
    Luis Izquierdo, Jose
    Resano, Pilar
    El Hachem, Abdulkader
    Graziani, Desire
    Almonacid, Carlos
    Sanchez, Ignacio M.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 : 1053 - 1058
  • [44] Polypharmacy among older advanced lung cancer patients taking EGFR tyrosine kinase inhibitors
    Hakozaki, Taiki
    Matsuo, Takuma
    Shimizu, Akihiro
    Ishihara, Yoko
    Hosomi, Yukio
    JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (01) : 64 - 71
  • [45] A phase II trial of perifosine in patients with advanced renal cell carcinoma (RCC) who have failed tyrosine kinase inhibitors (TKI)
    Cho, D. C.
    Figlin, R. A.
    Flaherty, K. T.
    Michaelson, D.
    Sosman, J. A.
    Ghebremichael, M.
    Bowers, M. E.
    Mier, J. W.
    Atkins, M. B.
    McDermott, D. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] Side effects of treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukemia and the occurrence of anxiety symptoms
    Gibek, Katarzyna
    Sacha, Tomasz
    Cyranka, Katarzyna
    PSYCHIATRIA POLSKA, 2024, 58 (01) : 25 - 38
  • [47] Side effects of treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukaemia and the occurrence of depressive symptoms
    Gibek, Katarzyna
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2023, 27 (04): : 277 - 283
  • [48] Tyrosine kinase inhibitors in patients with radioiodine-refractory, differentiated thyroid cancer Is there an optimal timepoint for their use?
    Rendl, Gundula
    Schweighofer-Zwink, Gregor
    Pirich, Christian
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2023, 16 (01): : 8 - 16
  • [49] Adrenal insufficiency in thyroid cancer patients treated with tyrosine kinase inhibitors and detected by ACTH stimulation test
    Valerio, L.
    Giani, C.
    Matrone, A.
    Pontillo-Contillo, B.
    Minaldi, E.
    Agate, L.
    Molinaro, E.
    Elisei, R.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2023, 46 (08) : 1663 - 1671
  • [50] Adrenal insufficiency in thyroid cancer patients treated with tyrosine kinase inhibitors and detected by ACTH stimulation test
    L. Valerio
    C. Giani
    A. Matrone
    B. Pontillo-Contillo
    E. Minaldi
    L. Agate
    E. Molinaro
    R. Elisei
    Journal of Endocrinological Investigation, 2023, 46 : 1663 - 1671
12345